Host immunity to commensal gut fungi

宿主对共生肠道真菌的免疫力

基本信息

  • 批准号:
    8340682
  • 负责人:
  • 金额:
    $ 45.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Many studies have documented the essential role that specific intestinal bacteria play in tuning mucosal immunity and in instructing tissue development and repair, but we know very little about how intestinal fungi interact with the immune system or contribute to intestinal inflammatory diseases. Studies cataloging intestinal microbes have typically focused on the bacteria, and the terms "intestinal bacteria" and "intestinal microbiome" are often used interchangeably. Two barriers to developing a better understanding of the role of gut fungi in health and disease are having a good sense of the numbers and types of fungi in the gut and having a model in which immune responses to gut fungi can be manipulated. My laboratory has been studying the role of the ?-glucan receptor Dectin-1 in host defense. Dectin-1 is expressed on macrophages and dendritic cells and is essential for defense against fungi. Dectin-1 signals inflammatory responses through an intracellular signaling adaptor molecule called CARD9, a protein for which specific genetic variants are strongly associated with ulcerative colitis and Crohn's disease. We have observed that mice lacking Dectin-1 are more susceptible to acute colitis induced by DSS than wild type mice and that this enhanced sensitivity is due to intestinal fungi. We have begun to characterize the intestinal fungal microflora by high throughput multitag pyrosequencing and have identified several hundred intestinal fungi. Thus, we are developing a sense of the numbers and types of fungi in the gut and a model in which immune responses to gut fungi can be manipulated. Our overall hypothesis is that the ?-glucan receptor Dectin-1 is responsible for surveying the gut microflora for fungi and orchestrating a host immune response that shapes the microflora and contributes to intestinal inflammatory conditions. We will explore this hypothesis in four aims. In aim 1 we will characterize the fungal microbiome in wild type, Dectin-1-/-, and CARD9-/- mice in resting and inflamed conditions. In aim 2 we will define the role of Decitn-1 in sampling intestina fungi and the role of intestinal fungi in driving inflammatory responses. In aim 3 we will determine whether mice lacking CARD9 exhibit the same fungal-driven intestinal inflammation as observed in Dectin-1 knockout mice. In aim 4 we will determine whether Dectin-1 and CARD9 knockout mice also exhibit enhanced susceptibility to spontaneous disease and disease induced by T cell transfer. PUBLIC HEALTH RELEVANCE: The intestines are full of microbes, and the numbers and kinds of microbes found there can be a significant factor in intestinal chronic inflammatory disease such as Inflammatory Bowel Disease. While many studies have focused on how intestinal bacteria are detected by the immune system, little is known about how intestinal fungi are detected. This study aims to define the repertoire of fungi found in mouse intestines and use mice lacking specific genes to understand how the immune system interacts with intestinal fungi.
描述(由申请人提供):许多研究已经记录了特定肠道细菌在调节粘膜免疫和指导组织发育和修复中发挥的重要作用,但我们对肠道真菌如何与免疫系统相互作用或导致肠道炎症性疾病知之甚少。对肠道微生物进行分类的研究通常集中在细菌上,并且术语“肠道细菌”和“肠道微生物组”经常互换使用。更好地理解肠道真菌在健康和疾病中的作用的两个障碍是对肠道中真菌的数量和类型有很好的了解,并有一个模型可以操纵对肠道真菌的免疫反应。我的实验室一直在研究?葡聚糖受体Dectin-1在宿主防御中的作用Dectin-1在巨噬细胞和树突状细胞上表达,对于防御真菌至关重要。Dectin-1通过称为CARD 9的细胞内信号转导衔接分子发出炎症反应信号,CARD 9是一种蛋白质,其特定的遗传变异与溃疡性结肠炎和克罗恩病密切相关。我们已经观察到,缺乏Dectin-1的小鼠比野生型小鼠更容易受到DSS诱导的急性结肠炎的影响,这种增强的敏感性是由于肠道真菌。我们已经开始通过高通量多标签焦磷酸测序来表征肠道真菌菌群,并且已经鉴定了数百种肠道真菌。因此,我们正在开发一种对肠道真菌数量和类型的认识,以及一种可以操纵对肠道真菌免疫反应的模型。我们的总体假设是?-葡聚糖受体Dectin-1负责调查肠道微生物菌群中的真菌,并协调宿主免疫反应,该免疫反应形成微生物菌群并促成肠道炎症状况。我们将从四个方面探讨这一假设。在 目的1我们将表征处于静息和发炎条件下的野生型、Dectin-1-/-和CARD 9-/-小鼠中的真菌微生物组。在目标2中,我们将定义Decitn-1在采样肠道真菌中的作用以及肠道真菌在驱动炎症反应中的作用。在目标3中,我们将确定缺乏CARD 9的小鼠是否表现出与在Dectin-1敲除小鼠中观察到的相同的真菌驱动的肠道炎症。在目标4中,我们将确定Dectin-1和CARD 9敲除小鼠是否也表现出对自发性疾病和由T细胞转移诱导的疾病的增强的易感性。 公共卫生关系:肠道充满了微生物,在肠道中发现的微生物的数量和种类可能是肠道慢性炎症性疾病(如炎症性肠病)的重要因素。虽然许多研究都集中在肠道细菌如何被免疫系统检测到,但对肠道真菌如何被检测到知之甚少。这项研究旨在确定小鼠肠道中发现的真菌库,并使用缺乏特定基因的小鼠来了解免疫系统如何与肠道真菌相互作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David M. Underhill其他文献

Peptidoglycan recognition by the innate immune system
先天免疫系统对肽聚糖的识别
  • DOI:
    10.1038/nri.2017.136
  • 发表时间:
    2018-01-02
  • 期刊:
  • 影响因子:
    60.900
  • 作者:
    Andrea J. Wolf;David M. Underhill
  • 通讯作者:
    David M. Underhill
PD19-01 EVALUATION OF THE VAGINAL MYCOBIOME IN ASYMPTOMATIC PRE-MENOPAUSAL WOMEN
  • DOI:
    10.1016/j.juro.2018.02.991
  • 发表时间:
    2018-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Victoria Scott;Jie Tang;Tiina Drell;Jaak Simm;Andres Salumets;Madis Metsis;David M. Underhill;A. Lenore Ackerman
  • 通讯作者:
    A. Lenore Ackerman
Non-protective immune imprint underlies failure of emStaphylococcus aureus/em IsdB vaccine
金黄色葡萄球菌 IsdB 疫苗失败的基础是非保护性免疫印记
  • DOI:
    10.1016/j.chom.2022.06.006
  • 发表时间:
    2022-08-10
  • 期刊:
  • 影响因子:
    18.700
  • 作者:
    Chih-Ming Tsai;J.R. Caldera;Irshad A. Hajam;Austin W.T. Chiang;Chih-Hsiung Tsai;Haining Li;María Lázaro Díez;Cesia Gonzalez;Desmond Trieu;Gislâine A. Martins;David M. Underhill;Moshe Arditi;Nathan E. Lewis;George Y. Liu
  • 通讯作者:
    George Y. Liu

David M. Underhill的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David M. Underhill', 18)}}的其他基金

Measuring Phagosomal Temperatures
测量吞噬体温度
  • 批准号:
    8698868
  • 财政年份:
    2014
  • 资助金额:
    $ 45.18万
  • 项目类别:
Measuring Phagosomal Temperatures
测量吞噬体温度
  • 批准号:
    8796150
  • 财政年份:
    2014
  • 资助金额:
    $ 45.18万
  • 项目类别:
Host immunity to commensal gut fungi
宿主对共生肠道真菌的免疫力
  • 批准号:
    8490371
  • 财政年份:
    2012
  • 资助金额:
    $ 45.18万
  • 项目类别:
Host immunity to commensal gut fungi
宿主对共生肠道真菌的免疫力
  • 批准号:
    9598612
  • 财政年份:
    2012
  • 资助金额:
    $ 45.18万
  • 项目类别:
Host immunity to commensal gut fungi
宿主对共生肠道真菌的免疫力
  • 批准号:
    8690040
  • 财政年份:
    2012
  • 资助金额:
    $ 45.18万
  • 项目类别:
Host immunity to commensal gut fungi
宿主对共生肠道真菌的免疫力
  • 批准号:
    10160894
  • 财政年份:
    2012
  • 资助金额:
    $ 45.18万
  • 项目类别:
Phagosomal targeting of CARD proteins
CARD 蛋白的吞噬体靶向
  • 批准号:
    8074174
  • 财政年份:
    2010
  • 资助金额:
    $ 45.18万
  • 项目类别:
Innate Immune Sensing of Bacterial Sugars
细菌糖的先天免疫感应
  • 批准号:
    8442856
  • 财政年份:
    2008
  • 资助金额:
    $ 45.18万
  • 项目类别:
Dectin-1 Signaling Mechanisms
Dectin-1 信号传导机制
  • 批准号:
    8629147
  • 财政年份:
    2008
  • 资助金额:
    $ 45.18万
  • 项目类别:
Non-Toll-like receptor innate immune signaling
非 Toll 样受体先天免疫信号传导
  • 批准号:
    7540386
  • 财政年份:
    2008
  • 资助金额:
    $ 45.18万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 45.18万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 45.18万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 45.18万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.18万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 45.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 45.18万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 45.18万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 45.18万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 45.18万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 45.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了